Previous 10 | Next 10 |
Summary Shares have lost two-thirds of their value this year. AQST-109 looks like an appealing alternative to Epi-Pen with greater convenience and more consistent, rapid response. Libervant tentative approval by the FDA was disappointing as there's clearly a difference in food...
Summary After 8 months of waiting for an update from the FDA, the agency finally announced a tentative approval for Aquestive's Libervant. Unfortunately, the company cannot market the product. Aquestive Therapeutics recently reported their Q2 earnings, which revealed a beat on rev...
WARREN, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the managemen...
Aquestive Therapeutics ( NASDAQ: AQST ), a company focused on different formulations of drugs announced Wednesday that the FDA granted tentative approval for Libervant (diazepam) Buccal Film for acute treatment of seizure in epilepsy patients aged 12 years and older. Speci...
Libervant provided tentative approval from the FDA for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity Libervant U.S. Market Access currently subject to the expiration of Valtoco® orphan drug market exclusivity Company hosts conference...
3 Ways That Inflation Impacts Investing in Penny Stocks When it comes to trading penny stocks, investors need to know everything that is going on in the stock market. Inflation is a huge factor when it comes to penny stocks , especially in the past few months. When inflation rates a...
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of Directors Names Kenneth Truitt, M.D., with over 25 years of clinical and regulatory experience across biotechnology and large pharmaceu...
Euro Tech Holdings Company ( CLWT ) +39% . SilverSun Technologies ( SSNT ) +28% . Aethlon Medical ( AEMD ) +19% CEO Chuck Fisher on Q1 2023 Results - Earnings Call Transcript. The Trade Desk ( TTD ) +16% Inc. 2023 Q2 - Results - Earnings C...
Image source: The Motley Fool. Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q2 2022 Earnings Call Aug 03, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Tran...
Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Conference Call August 03, 2022 08:00 AM ET Company Participants Bennett Watson - ICR Westwicke, Investor Relations Dan Barber - Chief Executive Officer Ernie Toth - Chief Financial Officer Dr. Steve Wargac...
News, Short Squeeze, Breakout and More Instantly...
Aquestive Therapeutics Inc. Company Name:
AQST Stock Symbol:
NASDAQ Market:
Aquestive Therapeutics Inc. Website:
Meets primary study endpoints with pharmacokinetics (PK) comparable whether Anaphylm is administered by subjects or by healthcare providers (HCPs) Final supportive study, the Oral Allergy Syndrome (OAS) challenge study, currently enrolling Continues to anticipate requesting a pr...
WARREN, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...
WARREN, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...